產(chǎn)品中心
Product Center
熱門搜索：
Fitzgerald Industries International代理
Envirologix 轉(zhuǎn)基因快速檢測(cè)試紙
Epitomics現(xiàn)貨抗體目錄
ABgene代理30
Cayman Chemical 特約代理
EVE™ Slide（EVE細(xì)胞計(jì)數(shù)板）
法國(guó)ID-VET
美國(guó)Sutter 玻璃毛坯 BF100-50-10
Sinobio公司產(chǎn)品介紹
Abcam代理
genview
D12079BWestern Diet(高純度飼料)
TEAA Solution（貨號(hào)：553303;SP5890）
LSPN-50ABMI公司LYSOSTAPHIN中國(guó)總代理
天然小鼠補(bǔ)體C1q蛋白
merck 2012年價(jià)格表
當(dāng)前位置：首頁(yè)
產(chǎn)品中心其他-其他plactest
plactest
產(chǎn)品簡(jiǎn)介
diaDexus (DDXS) is a medical diagnostics company, located in South San Francisco, California, focused on the development and commercialization of patent-protected in vitro diagnostic products addressing significant unmet needs in cardiovascular disease.
diaDexus’ first product, the PLAC® Test for Lp-PLA2, helps identify individuals at increased risk of suffering a heart attack or stroke, the #1 and #4 causes of death respectively in the U.S. These events can be prevented through early detection and more aggressive risk-reducing strategies.
For more information, please visit www.diadexus.com.
diaDexus has received FDA clearance to market the PLAC Test as an aid in the prediction of risk for coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis. The PLAC Test determines levels of Lp-PLA2 (lipoprotein-associated phospholipase A2) in the blood; individuals with elevated levels of Lp-PLA2 have been shown to have an increased risk of ischemic stroke and coronary heart disease.
上一個(gè)：
返回列表
